← All trials
NCT05408026
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2022
- Primary completion
- Oct 1, 2025
- Completion date
- Feb 28, 2026
- First posted
- Jun 7, 2022
- Last posted
- Sep 19, 2022
- Enrollment
- 84
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Alliance Foundation TrialsLead sponsor
- CelgeneCollaborator
- Janssen Pharmaceutica NVCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.